Navigation Links
Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
Date:10/23/2007

ding the University of Pittsburgh and the University of California, San Diego. Jennerex is planning to initiate a Phase 2a for squamous cell head and neck cancers in early 2008. The company also plans to conduct clinical trials for patients with lung cancer and melanoma.

"The broad clinical efficacy reported by these investigators strongly validates this first-in-class product, JX-594, and its novel mechanism-of-action. These exciting clinical results mirror closely what has been reported in preclinical studies," said David H. Kirn, M.D., CEO and President of Jennerex. "We are extremely grateful for the support of our clinical collaborators, as well as for the sponsorship of our partners for South Korea at Green Cross Corporation."

"We are very pleased to be collaborating with Jennerex for the development of this kind of exciting new drug, JX-594, in Korea," said B.G. Rhee, Ph.D., executive vice president of Green Cross. Jennerex has an exclusive partnership with Green Cross for the South Korean market only.

About JX-594

Jennerex's lead product candidate, JX-594, is a genetically-engineered vaccinia virus strain that is uniquely suited to treat cancers. It is designed to destroy both injected and non-injected metastatic tumors.

About Jennerex

Jennerex Biotherapeutics is a clinical stage biotherapeutics company working to create, develop and commercialize first-in-class cancer products. The company's products are engineered viruses that have been modified to be safe and effective against various forms of cancer. Jennerex products seek to kill cancer by targeting, attacking and eradicating cancer cells. The company's lead product candidate, JX-594, demonstrated clear anti-cancer effects in patients in a Phase 1 / 2 clinical trial. A Phase 2a clinical trial for liver cancer is currently being initiated. A Phase 2 trial for JX-594 in squamous cell head and neck cancer is expected to begin in the first quarter of 2008. JX-594 is the fi
'/>"/>

SOURCE Jennerex Biotherapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. Pharmexa A/S (DK) - Pharmexa presents data from influenza program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 ... of the "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, ... - 2020" report to their offering. ... market (types, applications and geography) - Size, Share, ... Report, Opportunities, Segmentation and Forecast, 2013 - 2020", ...
(Date:8/20/2014)... , Aug. 20, 2014 Research and Markets ... of Pralmorelin" report to their offering. ... comprehensive data on Pralmorelin globally and regionally ( Europe ... America , Latin America etc.). ... This report focuses on three primary areas; manufacture ...
(Date:8/20/2014)... 2014 Reportlinker.com announces that a new ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for ... the following Product Segments: Active Coatings, Protective Coatings, ... separate comprehensive analytics for the US, ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... 2011 CardioMEMS, Inc ., an Atlanta-based medical ... proprietary wireless sensing and communication technology for the human ... Yadav, M.D., was presented with a Health-Care Heroes Award ... Business Chronicle.  The award was conferred on Dr. Yadav ...
... 2011 CardioGenics Holdings Inc. (CGNH: OTCB) announced today ... presenting at the 7th Annual Spring Growth Stock Conference ... be held on Tuesday, May 24th at the Omni ... will include a select group of institutional portfolio managers ...
Cached Medicine Technology:CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 2CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 3CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc. 2CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc. 3
(Date:8/21/2014)... Baltimore, MD 21218 (PRWEB) August 21, 2014 ... company dedicated to aging interventions and addressing ... proposes a new concept, OncoFinder, for signalome-wide ... for accurate and robust cross-platform analysis of ... , The original research, published in the ...
(Date:8/20/2014)... Illinois (PRWEB) August 21, 2014 On September ... The Walk MS organization connects people living with MS with ... two million dollars and are 85% of the way to ... Junction City, registration begins at 11:30 and the walk starts ... will be available to answer question about chiropractic care and ...
(Date:8/20/2014)... 21, 2014 PAINWeek, the National ... that Ethan Nadelmann, JD, PhD, will deliver the ... the founder and executive director of the Drug ... States promoting alternatives to the war on drugs. ... both domestically and internationally, he has played a ...
(Date:8/20/2014)... August 21, 2014 Top10BestSEOHosting.com is ... reviews about hosting products. It is headed by ... experience. The site offers research-based information and factual ... suppliers in the current market. , Recently, ... announced that GoDaddy and Bluehost are ...
(Date:8/20/2014)... A new trend in the insurance ... before issuing an approximate quote for insurance coverage, according ... helping the public to obtain life insurance quotes without ... http://quotespros.com/life-insurance.html . , The coverage industry has changed ... appeared in many U.S. states. Some consumers are now ...
Breaking Medicine News(10 mins):Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:PAINWeek Welcomes Ethan Nadelmann, JD, PhD, as Keynote Speaker at 2014 Conference 2Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2
... Chief Science Officer Geri Dawson, Ph.D. and Assistant VP, Head of ... Hour: The Doctors Are In," a monthly live web chat with ... from 3:00 - 4:00 pm Eastern / 12:00 noon - 1:00 ... time of the web chat, viewers simply log in via the ...
... Salamon HealthDay Reporter , WEDNESDAY, Dec. 7 ... developing breast cancer by avoiding unnecessary medical radiation, forgoing ... don,t need to worry about using hair dyes or ... the body of research on environmental factors that may ...
... California,s low-income seniors with disabilities are struggling to remain in ... and may be slashed even further, according to a new ... with support from The SCAN Foundation. Should ... to In-Home Supportive Services (IHSS) on Dec. 15, as proposed ...
... NY)An antimalarial agent developed by researchers at Albert ... effective at clearing infections caused by the malaria parasite ... parasites to death. The novel research, carried out on ... to develop more potent therapies against one of the ...
... the main cause of complications and death from cancer. For ... development of these metastases themselves, instead of focusing on the ... a team from the Swiss Center for Experimental Cancer Research ... plays a major role in metastasis development, and showed that ...
... Fla. -- The use of two drugs never tried in ... 70 percent destruction of cancer cells already resistant to commonly ... Florida . Their report, published online in Gynecologic ... might offer a much needed treatment option for women with ...
Cached Medicine News:Health News:New Autism Speaks 'Office Hour: The Doctors Are In' monthly live web chat 2Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 2Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 3Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 4Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 2Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 3Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 4Health News:Novel drug wipes out deadliest malaria parasite through starvation 2Health News:Novel drug wipes out deadliest malaria parasite through starvation 3Health News:Nipping metastases in the bud 2Health News:Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells 2
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
... Prodisc design is based upon the ... natural spinal motion segment unit. Kinematics ... integrates the biomechanical and anatomical aspects ... concept: Three implant components utilizing proven ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
Designed for use during surgical procedures under fluoroscopy. A very practical unit, the frames superior design eliminates problems associated with imaging....
Medicine Products: